Articles & Video
Survey: Antibody Engineering & Therapeutics State of the Industry 2021
What has changed in antibody engineering and antibody-based therapeutics over the last year? Tell us your experience in our industry survey.
eBook: Antibody Discovery, Selection & Screening
This ebook uncovers the latest approaches and emerging tools for therapeutic antibody discovery.
Novel Non-cancer Targets for Therapeutic Antibodies
We look at the latest work on developing non-cancer targets for therapeutic antibodies discussed by industry leaders at Antibody Engineering & Therapeutics.
Novel Antibody Therapeutic Modalities - Antibody Therapeutics eBook Series
We take an in-depth look at the novel antibody therapeutic modalities being developed and how they are tackling new non-cancer targets in this Antibody Therapeutics eBook.
Podcast: How to Create the Ultimate Bispecific
What goes into making the perfect bispecific? In our first Life Sciences podcast, we find out the best steps from Volker Schellenberger at Amunix.
REPORT: Antibody Therapeutic Modalities 2020
Global research study into the development, targets, challenges and technologies of different antibody therapeutic modalities.
COVID-19 antibody therapeutic development - WHITEPAPER
This paper evaluates the antibody therapies for COVID-19 currently in clinical trials and preclinical development.
Antibody Engineering and Therapeutics Survey: Tell us your views
Take part in our huge antibody therapeutic modalities survey to be in with a chance of winning a free conference pass.
The Future of Antibody Engineering and Therapeutics - eBook Series
In the first of our Antibody Therapeutics eBook Series, we take an in-depth look at how the latest technologies and strategies are shaping the future of the industry.
Novel technologies and approaches for optimizing antibody discovery - WHITEPAPER
This whitepaper examines some of the latest advancements in methods and technologies innovating the discovery of antibodies.
Emerging technologies in antibody engineering and therapeutics
This whitepaper looks at the latest emerging technologies and novel approaches to antibody engineering and therapeutics.
Bispecific antibody engineering and therapeutics - WHITEPAPER
The whitepaper explores the latest developments, technologies and challenges in bispecific antibody engineering and therapeutics. Download it here.
INDUSTRY VOICES: Next gen biologics benefits, investment and challenges
Four industry experts discuss the benefits, investment and challenges around next generation biologics.
The Future of Monoclonal Antibodies - WHITEPAPER
This whitepaper explores the current state and future of the monoclonal antibodies market and FDA approved monoclonal antibodies.